References
- Walsh NP , GleesonM, ShephardRJ et al. Position statement. Part one: immune function and exercise. Exerc. Immunol. Rev. 17 , 6–63, (2011).
- Nieman DC , JohansenLM, LeeJW, ArabatzisK. Infectious episodes in runners before and after the Los Angeles Marathon. J. Sports Med. Phys. Fitness30 , 316–328 (1990).
- Alonso JM , EdouardP, FischettoG, AdamsB, DepiesseF, MountjoyM. Determination of future prevention strategies in elite track and field: analysis of Daegu 2011 IAAF Championships injuries and illnesses surveillance. Br. J. Sports Med.46(7) , 505–514 (2012).
- Walsh NP , GleesonM, PyneDB et al. Position Statement. Part two: maintaining immune health. Exerc. Immunol. Rev. 17 , 64–103, (2011).
- Gleeson M , BishopNC, OliveiraM, McCauleyT, TaulerP, MuhamadAS. Respiratory infection risk in athletes: association with antigen-stimulated IL-10 production and salivary IgA secretion. Scand. J. Med. Sci. Sports22 , 410–417, (2012).
- Spence L , BrownWJ, PyneDB et al. Incidence, etiology, and symptomatology of upper respiratory illness in elite athletes. Med. Sci. Sports Exerc. 39(4) , 577–586, (2007).
- Cox AJ , GleesonM, PyneDB, CallisterR, HopkinsWG, FrickerPA. Clinical and laboratory evaluation of upper respiratory symptoms in elite athletes. Clin. J. Sport Med.18 , 438–445 (2008).
- Bermon S . Airway inflammation and upper respiratory tract infection in athletes: is there a link? Exerc. Immunol. Rev.13 , 6–14 (2007).
- Robson-Ansley P , HowatsonG, TallentJ et al. Prevalence of allergy and upper respiratory tract symptoms in runners of the London Marathon. Med. Sci. Sports Exerc. 44(6) , 999–1004 (2012).